|
|
- Mitchel Sayare, Ph.D.
Chairman, President and Chief Executive Officer, ImmunoGen, Inc.
- David W. Carter
Formerly Chairman and Chief Executive Officer, Xenogen, Inc.
- Stephen C. McCluski
Formerly Senior Vice President and Chief Financial Officer, Baush & Lomb, Inc.
- Nicole Onetto, M.D.
Senior Vice President, Product Development and Chief Medical Officer, ZymoGenetics, Inc.
- Mark Skaletsky
Chairman and Chief Executive Officer, Trine Pharmaceuticals, Inc.
- Joseph J. Villafranca, Ph.D.
Practice Director, Pharmaceuticals/Life Sciences, Tunnell Consulting
- Richard Wallace
Formerly Senior Vice President of Research and Development at GlaxoSmithKline
|
